SCHEMBL26324800

SCHEMBL26324800

CC(C)OC(=O)C(C(C)C)N(c1ccccc1)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.42
PDCD1 Q15116 1/20 0.41
CD274 Q9NZQ7 1/20 0.41
HTT P42858 3/20 0.39
SMN1; SMN2 Q16637 4/20 0.38
GAA P10253 1/20 0.38
KMT2A Q03164 2/20 0.38
CHRNB2 P17787 1/20 0.38
CHRNB4 P30926 1/20 0.38
CHRNA3 P32297 1/20 0.38
CHRNA4 P43681 1/20 0.38
MMP2 P08253 2/20 0.38
MMP9 P14780 2/20 0.38
MMP8 P22894 2/20 0.38
MMP13 P45452 2/20 0.38
MMP3 P08254 1/20 0.38
MMP12 P39900 1/20 0.38
MMP14 P50281 1/20 0.38
MMP16 P51512 1/20 0.38
ALDH1A1 P00352 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26324955 0.92 PDCD1 (0.50) TSHRPDCD1CD274GAAMMP2
SCHEMBL26324940 0.92 TRPM8 (0.39) TSHRPDCD1CD274HTTSMN1; SMN2
SCHEMBL26325014 0.91 PDCD1 (0.51) TSHRPDCD1CD274GAAMMP2
SCHEMBL26324957 0.90 PTGS1 (0.41) SMN1; SMN2MMP2MMP9MMP8MMP13
SCHEMBL26324995 0.88 PTGS1 (0.42) SMN1; SMN2MMP2MMP9MMP8MMP13
SCHEMBL26325013 0.87 PDCD1 (0.44) PDCD1CD274MMP2MMP9MMP8
SCHEMBL26324873 0.85 TSHR (0.41) TSHRPDCD1CD274HTTSMN1; SMN2
SCHEMBL26324999 0.85 ALOX5 (0.37) TSHRHTTGAAKMT2AALDH1A1
SCHEMBL26324997 0.83 MEN1 (0.44) TSHRSMN1; SMN2KMT2ACHRNB2CHRNB4
SCHEMBL25440144 0.82 TSHR (0.44) TSHRPDCD1CD274HTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11767291-B2 Preparation of secondary amines with electrophilic N-linchpin reagents WILLIAM MARSH RICE UNIVERSITY (US) 2023-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11767291-B2 Preparation of secondary amines with electrophilic N-linchpin reagents PNMT, NCL, NPM1 TSHR 2716/4885PDCD1 3686/4885CD274 4128/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.